Fertility Road Issue 14

Is there an example of where Eeva helped provide
insight that you wouldn’t otherwise have had?
It has been particularly useful to review the Eeva images
on day 3, and compare the traditional methods of embryo
assessment. On some occasions, an embryo may appear to have
reached the right cell stage, - but reviewing the images has
revealed that the embryo did not meet the cell division parameters
at the correct time, and we have then not selected the embryo for
transfer. We have continued to culture these embryos until day 5
and have found a high correlation with failed blastocyst formation
in these embryos.
How can your patients learn more about Eeva
if they are interested in this procedure?
Wessex Fertility patients interested in Eeva can call us at 023
8070 6000 to learn more. We also have a dedicated page on our
website (www.wessexfertility.com/eeva). Additionally we have regular
information seminars where we explain and discuss the use of Eeva.
Our Consultants and Nurses also discuss the use of Eeva at Initial
Patient Consultations and set up appointments.
For more information about the technology behind Eeva, including
the latest news and events please visit www.eevaivf.com..
About Eeva
The new Eeva test is clinically proven to help embryologists better
select viable embryos at an early stage. The test was developed based
on research conducted at Stanford University, which discovered that
correlations in early cell division timings and the underlying health
of the embryo can help determine the viability of the embryo.
At the heart of Eeva is intelligent software that reliably and
consistently assesses critical and subtle differences in early embryo
development. This data helps IVF clinicians determine an embryo’s
viability and select the embryos with the highest potential for transfer
or freezing. Eeva is designed to safely identify which embryos are
most likely to develop to blastocyst stage – a critical stage in embryo
development that typically happens on Day 5 or 6. With access to this
unique information, an IVF team can more accurately select the best
embryo(s) for transfer which could improve pregnancy chances.
In a clinical study of 755 embryos, embryologists using Eeva
in combination with their traditional methods were able to
significantly improve their ability to correctly identify non-viable
embryos (85% of the time when using Eeva vs. only 60% of the time
when using traditional methods).
The Eeva Test is also available at CRM London, GCRM in
Glasgow, Hewitt Fertility Centre in Liverpool, Sims IVF in Ireland
and is coming soon to Bourn Hall in Cambridge.
APRIL - MAY 2013 | WWW.FERTILITYROAD.COM |
19